Emerging Technologies
Roundup: 'On-the-spot' COVID-19 test receives CE Mark, Thriva launches women's hormones test and mo…
Also, startup creates wearable tech to tackle head injuries in sport.
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution.
European digital health coaching company, Liva Healthcare and global biotechnology organisation, Amgen, have announced a partnership to make cardiac rehabilitation accessible to patients following a heart attack.
The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.
The technology release launches the delayed MedTech Funding Mandate that accelerates uptake of innovative treatments and therapies.
The funds will be used to develop the firm’s non-invasive blood sensing technology.
The sterilisation method has been used in hospitals and laboratories for more than 50 years.
System which identifies patients at risk of fatal heart attack obtains CE mark.
Concerns raised that EU Health Technology Assessment Regulation could lead to delays in market approval.
Companies will shed light on immunotherapy, an emerging therapeutic approach that helps the immune system fight cancer, in a brand-new study on one of the most impacting cancers worldwide.